GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus

Med Clin (Barc). 2018 Jul 13;151(1):39.e1-39.e17. doi: 10.1016/j.medcli.2017.11.037. Epub 2018 Jan 19.
[Article in English, Spanish]

Abstract

The incidence of non-Hodgkin's lymphoma and Hodgkin's lymphoma is higher in patients with HIV infection than in the general population. Following the introduction of combination antiretroviral therapy (cART), the prognostic significance of HIV-related variables has decreased, and lymphoma-related factors have become more pronounced. Currently, treatments for lymphomas in HIV-infected patients do not differ from those used in the general population. However, differentiating characteristics of seropositive patients, such as the need for cART and specific prophylaxis and treatment of certain opportunistic infections, should be considered. This document updates recommendations on the diagnosis and treatment of lymphomas in HIV infected patients published by GESIDA/PETHEMA in 2008.

Keywords: AIDS; Antiretroviral therapy; HIV; Hodgkin's lymphoma; Linfoma de Hodgkin; Linfoma no hodgkiniano; Non-Hodgkin's lymphoma; Sida; Tratamiento antirretroviral; VIH.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Combined Modality Therapy
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Hodgkin Disease* / complications
  • Hodgkin Disease* / diagnosis
  • Hodgkin Disease* / therapy
  • Humans
  • Lymphoma, Non-Hodgkin* / complications
  • Lymphoma, Non-Hodgkin* / diagnosis
  • Lymphoma, Non-Hodgkin* / therapy
  • Prognosis

Substances

  • Anti-HIV Agents